Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1806
TNBC
Basal A
Chloroquine
12702.177
uM
5.96530
9.57550
-0.6177 -0.6675 1.7918 0.2519
0.9986
1.5730
HCC1954
HER2amp
Basal A
Methylglyoxal
13631.184
uM
inf
inf
-0.9647 -0.9647 0.0000 0.6967
0.4015
1.3577
EFM-192A
HER2amp
Luminal
Ribavirin
15284.211
uM
73.29440
62.64580
0.8208 0.2710 4.9741 0.0019
0.6080
0.8976
Hs 578T
TNBC
Basal B
Chloroquine
12622.177
uM
5.16760
8.74240
-0.6678 -0.7210 1.6981 0.2810
0.9997
2.5433
HCC1806
TNBC
Basal A
Glycyl-H-1152
ROCK2
12239.16
uM
inf
8.170
0.6981 0.6893 1.6228 0.0296
0.9372
1.8654
SUM1315MO2
TNBC
Basal B
CGC-11047
Polyamine analogue
9797.006
uM
240.24350
316.40620
-1.0000 -1.0000 3.9895 0.5345
0.9201
0.4196
SUM1315MO2
TNBC
Basal B
CGC-11047
Polyamine analogue
10139.034
uM
747.5240
1000.00000
-0.9445 -0.7365 3.1115 0.2590
0.8815
0.8381
MCF 10A
NM
Basal B
Methylglyoxal
13551.184
uM
680.90370
999.99950
-0.2926 -0.2104 0.9138 0.3902
0.9470
3.0171
MCF 10A
NM
Basal B
CGC-11047
Polyamine analogue
7870.018
uM
265.4420
530.97710
-0.7548 -0.8469 1.4293 0.4668
0.8849
2.2478
SUM159PT
TNBC
Basal B
Torkinib
15402.211
uM
0.01202
0.01610
-0.0537 -0.0724 0.4628 0.6556
0.9950
3.0887
MCF7
HR+
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
7875.016
uM
36.8150
155.18220
-0.0965 -1.0000 0.7636 0.1967
0.9078
1.6229
MDA-MB-157
TNBC
Basal B
Methylglyoxal
13611.184
uM
444.34060
663.74310
-0.9810 -0.8867 2.5419 0.7713
0.9453
0.8419
MCF 10A
NM
Basal B
Mebendazole
12944.174
uM
5.09360
7.17890
-0.0457 -0.1840 0.9131 0.2211
0.9985
2.7985
MCF 10F
NM
-
(Z)-4-Hydroxytamoxifen
ESR1
7871.016
uM
inf
34.66260
0.8429 0.8429 4.9988 -0.0104
0.6376
1.0272
MDA-MB-157
TNBC
Basal B
Nelfinavir
12632.174
uM
8.66770
10.84610
-0.9889 -0.9971 4.8914 0.1686
0.9955
0.8563
HCC2185
TNBC
Luminal
TAPI-0
TACE/Collagenase
7462.096
uM
0.31064
0.30734
-0.0269 0.0260 5.0000 0.3485
0.9689
0.3514
Hs 578T
TNBC
Basal B
CGC-11047
Polyamine analogue
7863.018
uM
93.13020
1000.00000
-0.7605 -0.9551 0.4500 0.3964
0.6501
2.0946
MCF 10F
NM
-
(Z)-4-Hydroxytamoxifen
ESR1
7872.016
uM
7.35710
5.64830
0.1459 0.2589 2.7594 0.2512
0.8956
1.4834
HCC38
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
9028.016
uM
inf
0.64162
0.7236 0.7617 4.7985 0.0777
0.8803
1.2348
MCF7
HR+
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
7874.016
uM
inf
7.93870
0.5977 0.4146 0.2796 0.1875
0.9565
1.5947
MDA-MB-436
TNBC
Basal B
CGC-11047
Polyamine analogue
10266.026
uM
105.61670
682.00580
-0.8390 -1.0000 0.5890 0.4418
0.8587
0.6682
HCC38
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7854.016
uM
inf
7.23080
0.3700 0.5045 5.0000 0.1340
0.8222
0.9074
HCC38
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
9453.019
uM
50.39440
91.7690
-0.5042 -1.0000 1.8329 0.1656
0.9890
1.1486
MCF7
HR+
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
9583.132
uM
inf
inf
0.9409 0.9409 0.0000 0.0291
0.4029
1.2070
MCF 10A
NM
Basal B
CGC-11047
Polyamine analogue
9551.026
uM
185.91980
1000.00000
-0.6377 -0.8853 0.6057 0.3813
0.7752
2.6508